239
Views
1
CrossRef citations to date
0
Altmetric
Articles

Quantitative adverse outcome pathway (qAOP) using bayesian network model on comparative toxicity of multi-walled carbon nanotubes (MWCNTs): safe-by-design approach

&
Pages 679-694 | Received 22 Jun 2022, Accepted 24 Oct 2022, Published online: 10 Nov 2022

References

  • Alfaro-Moreno, E., T. S. Nawrot, B. M. Vanaudenaerde, M. F. Hoylaerts, J. A. Vanoirbeek, B. Nemery, and P. H. M. Hoet. 2008. “Co-Cultures of Multiple Cell Types Mimic Pulmonary Cell Communication in Response to Urban PM10.” The European Respiratory Journal 32 (5): 1184–1194. doi:10.1183/09031936.00044008.
  • Allegri, M., D. K. Perivoliotis, M. G. Bianchi, M. Chiu, A. Pagliaro, M. A. Koklioti, A. F. A. Trompeta, E. Bergamaschi, O. Bussolati, and C. A. Charitidis. 2016. “Toxicity Determinants of Multi-Walled Carbon Nanotubes: The Relationship between Functionalization and Agglomeration.” Toxicology Reports 3: 230–243. doi:10.1016/j.toxrep.2016.01.011.
  • Ankley, G. T., R. S. Bennett, R. J. Erickson, D. J. Hoff, M. W. Hornung, R. D. Johnson, D. R. Mount, et al. 2010. “Adverse Outcome Pathways: A Conceptual Framework to Support Ecotoxicology Research and Risk Assessment.” Environmental Toxicology and Chemistry 29 (3): 730–741. doi:10.1002/etc.34.
  • Battegay, E. J., E. W. Raines, T. Colbert, and R. Ross. 1995. “TNF-Alpha Stimulation of Fibroblast Proliferation. Dependence on Platelet-Derived Growth Factor (PDGF) Secretion and Alteration of PDGF Receptor Expression.” The Journal of Immunology 154 (11): 6040–6047.
  • Bussy, C., M. Pinault, J. Cambedouzou, M. J. Landry, P. Jegou, M. Mayne-L’hermite, P. Launois, J. Boczkowski, and S. Lanone. 2012. “Critical Role of Surface Chemical Modifications Induced by Length Shortening on Multi-Walled Carbon Nanotubes-Induced Toxicity.” Particle and Fibre Toxicology 9 (1): 46. doi:10.1186/1743-8977-9-46.
  • Carriger, J. F., T. M. Martin, and M. G. Barron. 2016. “A Bayesian Network Model for Predicting Aquatic Toxicity Mode of Action Using Two Dimensional Theoretical Molecular Descriptors.” Aquatic Toxicology 180: 11–24. doi:10.1016/j.aquatox.2016.09.006.
  • Chatterjee, N, and J. Choi. 2020. “Endoplasmic Reticulum Stress Mediated Apoptosis via JNK in MWCNT-Exposed In Vitro Systems: size, Surface Functionalization and Cell Type Specificity.” The Journal of Toxicological Sciences 45 (6): 305–317. doi:10.2131/jts.45.305.
  • Chatterjee, N., J. Yang, H. M. Kim, E. Jo, P. J. Kim, K. Choi, and J. Choi. 2014. “Potential Toxicity of Differential Functionalized Multiwalled Carbon Nanotubes (MWCNT) in Human Cell Line (BEAS2B) and Caenorhabditis elegans.” Journal of Toxicology and Environmental Health. Part A 77 (22–24): 1399–1408. doi:10.1080/15287394.2014.951756.
  • Chatterjee, N., J. Yang, S. Kim, S. W. Joo, and J. Choi. 2016. “Diameter Size and Aspect Ratio as Critical Determinants of Uptake, Stress Response, Global Metabolomics and Epigenetic Alterations in Multi-Wall Carbon Nanotubes.” Carbon 108: 529–540. doi:10.1016/j.carbon.2016.07.031.
  • Chatterjee, N., J. Yang, D. Yoon, S. Kim, S. W. Joo, and J. Choi. 2017. “Differential Crosstalk between Global DNA Methylation and Metabolomics Associated with Cell Type Specific Stress Response by Pristine and Functionalized MWCNT.” Biomaterials 115: 167–180. doi:10.1016/j.biomaterials.2016.11.005.
  • Cheresh, P., S. J. Kim, S. Tulasiram, and D. W. Kamp. 2013. “Oxidative Stress and Pulmonary Fibrosis.” Biochimica et Biophysica Acta 1832 (7): 1028–1040. doi:10.1016/j.bbadis.2012.11.021.
  • Coccini, T., E. Roda, D. A. Sarigiannis, P. Mustarelli, E. Quartarone, A. Profumo, and L. Manzo. 2010. “Effects of Water-Soluble Functionalized Multi-Walled Carbon Nanotubes Examined by Different Cytotoxicity Methods in Human Astrocyte D384 and Lung A549 Cells.” Toxicology 269 (1): 41–53. doi:10.1016/j.tox.2010.01.005.
  • Ede, J. D., V. Lobaskin, U. Vogel, I. Lynch, S. Halappanavar, S. H. Doak, M. G. Roberts, and J. A. Shatkin. 2020. “Translating Scientific Advances in the AOP Framework to Decision Making for Nanomaterials.” Nanomaterials 10 (6): 1229. doi:10.3390/nano10061229.
  • Efron, B, and R. J. Tibshirani. 1993. An Introduction to the Bootstrap. London: Chapman and Hall/CRC.
  • Ema, M., H. Takehara, M. Naya, H. Kataura, K. Fujita, and K. Honda. 2017. “Length Effects of Single-Walled Carbon Nanotubes on Pulmonary Toxicity after Intratracheal Instillation in Rats.” The Journal of Toxicological Sciences 42 (3): 367–378. doi:10.2131/jts.42.367.
  • Eom, H., J. Jeong, and J. Choi. 2015. “Effect of Aspect Ratio on the Uptake and Toxicity of Hydroxylated-Multi Walled Carbon Nanotubes in the Nematode, Caenorhabditis elegans.” Environmental Health and Toxicology 30: e2015001. doi:10.5620/eht.e2015001.
  • Foran, C. M., T. Rycroft, J. Keisler, E. J. Perkins, I. Linkov, and N. Garcia-Reyero. 2019. “A Modular Approach for Assembly of Quantitative Adverse Outcome Pathways.” ALTEX 36 (3): 353–362. doi:10.14573/altex.1810181.
  • Fraczek-Szczypta, A., E. Menaszek, T. B. Syeda, A. Misra, M. Alavijeh, J. Adu, and S. Blazewicz. 2012. “Effect of MWCNT Surface and Chemical Modification on in Vitro Cellular Response.” Journal of Nanoparticle Research 14 (10): 1181. doi:10.1007/s11051-012-1181-1.
  • Franzdóttir, S. R., I. T. Axelsson, A. J. Arason, Ó. Baldursson, T. Gudjonsson, and M. K. Magnusson. 2010. “Airway Branching Morphogenesis in Three Dimensional Culture.” Respiratory Research 11 (1): 162. doi:10.1186/1465-9921-11-162.
  • Friedman, N., M. Goldszmidt, and A. Wyner. 1999. “Data Analysis with Bayesian Networks: A Bootstrap Approach.” Proceedings of the Fifteenth Conference on Uncertainty in Artificial Intelligence, 196–205.
  • Furxhi, I., F. Murphy, C. A. Poland, B. Sheehan, M. Mullins, and P. Mantecca. 2019. “Application of Bayesian Networks in Determining Nanoparticle-Induced Cellular Outcomes Using Transcriptomics.” Nanotoxicology 13 (6): 827–848. doi:10.1080/17435390.2019.1595206.
  • Gerloff, K., B. Landesmann, A. Worth, S. Munn, T. Palosaari, and M. Whelan. 2017. “The Adverse Outcome Pathway Approach in Nanotoxicology.” Computational Toxicology 1: 3–11. doi:10.1016/j.comtox.2016.07.001.
  • Halappanavar, S., S. Van Den Brule, P. Nymark, L. Gaté, C. Seidel, S. Valentino, V. Zhernovkov, et al. 2020. “Adverse Outcome Pathways as a Tool for the Design of Testing Strategies to Support the Safety Assessment of Emerging Advanced Materials at the Nanoscale.” Particle and Fibre Toxicology 17 (1): 1–24. doi:10.1186/s12989-020-00344-4.
  • Hamilton, R. F., Z. Wu, S. Mitra, P. K. Shaw, and A. Holian. 2013. “Effect of MWCNT Size, Carboxylation, and Purification on in Vitro and in Vivo Toxicity, Inflammation and Lung Pathology.” Particle and Fibre Toxicology 10 (1): 57. doi:10.1186/1743-8977-10-57.
  • Han, Y. guang, J. Xu, Z. gui Li, G. gang Ren, and Z. Yang. 2012. “In Vitro Toxicity of Multi-Walled Carbon Nanotubes in C6 Rat Glioma Cells.” Neurotoxicology 33 (5): 1128–1134. doi:10.1016/j.neuro.2012.06.004.
  • Heckerman, D, and J. S. Breese. 1996. “Causal Independence for Probability Assessment and Inference Using Bayesian Networks.” IEEE Transactions on Systems, Man, and Cybernetics 26 (6): 826–831. doi:10.1109/3468.541341.
  • Ibrahim, K. S. 2013. “Carbon Nanotubes-Properties and Applications: A Review.” Carbon Letters 14 (3): 131–144. doi:10.5714/CL.2013.14.3.131.
  • Jeong, J., T. Song, N. Chatterjee, I. Choi, Y. K. Cha, and J. Choi. 2018. “Developing Adverse Outcome Pathways on Silver Nanoparticle-Induced Reproductive Toxicity via Oxidative Stress in the Nematode Caenorhabditis elegans Using a Bayesian Network Model.” Nanotoxicology 12 (10): 1182–1197. doi:10.1080/17435390.2018.1529835.
  • Johnson, S., E. Abal, K. Ahern, and G. Hamilton. 2014. “From Science to Management: Using Bayesian Networks to Learn about Lyngbya.” Statistical Science 29 (1): 36–41. doi:10.1214/13-STS424.
  • Joshi, N., S. Watanabe, R. Verma, R. P. Jablonski, C. I. Chen, P. Cheresh, N. S. Markov, et al. 2020. “A Spatially Restricted Fibrotic Niche in Pulmonary Fibrosis is Sustained by M-CSF/M-CSFR Signalling in Monocyte-Derived Alveolar Macrophages.” European Respiratory Journal 55 (1): 1900646. doi:10.1183/13993003.00646-2019.
  • Kim, J. S., K. Lee, Y. H. Lee, H. S. Cho, K. H. Kim, K. H. Choi, S. H. Lee, K. S. Song, C. S. Kang, and I. J. Yu 2011. “Aspect Ratio Has No Effect on Genotoxicity of Multi-Wall Carbon Nanotubes.” Archives of Toxicology 85 (7): 775–786. doi:10.1007/s00204-010-0574-0.
  • Kleandrova, V. V., F. Luan, H. González-Díaz, J. M. Ruso, A. Speck-Planche, and M. N. D. S. Cordeiro. 2014. “Computational Tool for Risk Assessment of Nanomaterials: Novel QSTR-Perturbation Model for Simultaneous Prediction of Ecotoxicity and Cytotoxicity of Uncoated and Coated Nanoparticles under Multiple Experimental Conditions.” Environmental Science & Technology 48 (24): 14686–14694. doi:10.1021/es503861x.
  • Kostarelos, K. 2008. “The Long and Short of Carbon Nanotube Toxicity.” Nature Biotechnology 26 (7): 774–776. doi:10.1038/nbt0708-774.
  • Kraegeloh, A., B. Suarez-Merino, T. Sluijters, and C. Micheletti. 2018. “Implementation of Safe-by-Design for Nanomaterial Development and Safe Innovation: Why we Need a Comprehensive Approach.” Nanomaterials 8 (4): 239. doi:10.3390/nano8040239.
  • Lamon, L., D. Asturiol, A. Vilchez, J. Cabellos, J. Damásio, G. Janer, A. Richarz, and A. Worth. 2019. “Physiologically Based Mathematical Models of Nanomaterials for Regulatory Toxicology: A Review.” Computational Toxicology (Amsterdam, Netherlands) 9: 133–142. doi:10.1016/j.comtox.2018.10.002.
  • Lenz e Silva, G. F, and R. Hurt. 2017. “Risk Assessment of Nanocarbon Materials Using a Multi-Criteria Method Based on Analytical Hierarchy Process.” Current Bionanotechnology 2 (2): 106–111. doi:10.2174/2213529402666160601123940.
  • Li, K., M. F. van Delft, and Dewson, G. 2021. “Too Much Death Can Kill You: inhibiting Intrinsic Apoptosis to Treat Disease.” The EMBO Journal 40 (14): e107341. doi:10.15252/embj.2020107341.
  • Lynch, I., C. Weiss, and E. Valsami-Jones. 2014. “A Strategy for Grouping of Nanomaterials Based on Key Physico-Chemical Descriptors as a Basis for Safer-by-Design NMs.” Nano Today. 9 (3): 266–270. doi:10.1016/j.nantod.2014.05.001.
  • Micheletti, C., M. Roman, E. Tedesco, I. Olivato, and F. Benetti. 2017. “Implementation of the NANoREG Safe-by-Design Approach for Different Nanomaterial Applications.” Journal of Physics: Conference Series 838 (1): 012019. doi:10.1088/1742-6596/838/1/012019.
  • Murphy, F., B. Sheehan, M. Mullins, H. Bouwmeester, H. J. P. Marvin, Y. Bouzembrak, A. L. Costa, R. Das, V. Stone, and S. A. M. Tofail 2016. “A Tractable Method for Measuring Nanomaterial Risk Using Bayesian Networks.” Nanoscale Research Letters 11 (1): 503. doi:10.1186/s11671-016-1724-y.
  • Orrenius, S. 2019. “Role of Cell Death in Toxicology: Does It Matter How Cells Die?” Annual Review of Pharmacology and Toxicology 59: 1–14. doi:10.1146/annurev-pharmtox-010818-021725.
  • Palomäki, J., E. Välimäki, J. Sund, M. Vippola, P. A. Clausen, K. A. Jensen, K. Savolainen, S. Matikainen, and H. Alenius. 2011. “Long, Needle-like Carbon Nanotubes and Asbestos Activate the NLRP3 Inflammasome through a Similar Mechanism.” ACS Nano 5 (9): 6861–6870. doi:10.1021/nn200595c.
  • Perkins, E. J., P. Antczak, L. Burgoon, F. Falciani, N. Garcia-Reyero, S. Gutsell, G. Hodges, et al. 2015. “Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies with Different Degrees of Completeness and Scientific Confidence.” Toxicological Sciences : An Official Journal of the Society of Toxicology 148 (1): 14–25. doi:10.1093/toxsci/kfv181.
  • Perkins, E. J., R. Ashauer, L. Burgoon, R. Conolly, B. Landesmann, C. Mackay, C. A. Murphy, et al. 2019. “Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment.” Environmental Toxicology and Chemistry 38 (9): 1850–1865. doi:10.1002/etc.4505.
  • Perkins, E. J., K. Gayen, J. E. Shoemaker, P. Antczak, L. Burgoon, F. Falciani, S. Gutsell, et al. 2019. “Chemical Hazard Prediction and Hypothesis Testing Using Quantitative Adverse Outcome Pathways.” ALTEX 36 (1): 91–102. doi:10.14573/altex.1808241.
  • Poland, C. A., R. Duffin, I. Kinloch, A. Maynard, W. A. H. Wallace, A. Seaton, V. Stone, S. Brown, W. MacNee, and K. Donaldson. 2008. “Carbon Nanotubes Introduced into the Abdominal Cavity of Mice Show Asbestos-like Pathogenicity in a Pilot Study.” Nature Nanotechnology 3 (7): 423–428. doi:10.1038/nnano.2008.111.
  • R Core Team, 2015. “R: A Language and Environment for Statistical Computing.” R Foundation for Statistical Computing Vienna Austria.
  • Sanchez-Valle, V., N. C. Chavez-Tapia, M. Uribe, and N. Mendez-Sanchez 2012. “Role of Oxidative Stress and Molecular Changes in Liver Fibrosis: A Review.” Current Medicinal Chemistry 19 (28): 4850–4860. doi:10.2174/092986712803341520.
  • Sato, Y., A. Yokoyama, K. I. Shibata, Y. Akimoto, S. I. Ogino, Y. Nodasaka, T. Kohgo, et al. 2005. “Influence of Length on Cytotoxicity of Multi-Walled Carbon Nanotubes against Human Acute Monocytic Leukemia Cell Line THP-1 In Vitro and Subcutaneous Tissue of Rats In Vivo.” Molecular bioSystems 1 (2): 176–182. doi:10.1039/b502429c.
  • Sheehan, B., F. Murphy, M. Mullins, I. Furxhi, A. L. Costa, F. C. Simeone, and P. Mantecca. 2018. “Hazard Screening Methods for Nanomaterials: A Comparative Study.” International Journal of Molecular Sciences 19 (3): 649. doi:10.3390/ijms19030649.
  • Spinu, N., M. T. D. Cronin, S. J. Enoch, J. C. Madden, and A. P. Worth. 2020. “Quantitative Adverse Outcome Pathway (qAOP) Models for Toxicity Prediction.” Archives of Toxicology 94 (5): 1497–1510. doi:10.1007/s00204-020-02774-7.
  • Sweeney, S., D. Berhanu, S. K. Misra, A. J. Thorley, E. Valsami-Jones, and T. D. Tetley. 2014. “Multi-Walled Carbon Nanotube Length as a Critical Determinant of Bioreactivity with Primary Human Pulmonary Alveolar Cells.” Carbon 78: 26–37. doi:10.1016/j.carbon.2014.06.033.
  • Szegezdi, E., S. E. Logue, A. M. Gorman, and A. Samali. 2006. “Mediators of Endoplasmic Reticulum Stress-Induced Apoptosis.” EMBO Reports 7 (9): 880–885. doi:10.1038/sj.embor.7400779.
  • Utembe, W., H. Clewell, N. Sanabria, P. Doganis, and M. Gulumian. 2020. “Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.” Nanomaterials 10 (7): 1267. doi:10.3390/nano10071267.
  • Villeneuve, D. L., D. Crump, N. Garcia-Reyero, M. Hecker, T. H. Hutchinson, C. A. LaLone, B. Landesmann, et al. 2014. “Adverse Outcome Pathway (AOP) Development I: Strategies and Principles.” Toxicological Sciences 142 (2): 312–320. doi:10.1093/toxsci/kfu199.
  • Whitsett, J. A., T. V. Kalin, Y. Xu, and V. V. Kalinichenko. 2019. “Building and Regenerating the Lung Cell by Cell.” Physiological Reviews 99 (1): 513–554. doi:10.1152/physrev.00001.2018.
  • Wittwehr, C., H. Aladjov, G. Ankley, H. J. Byrne, J. de Knecht, E. Heinzle, G. Klambauer, et al. 2017. “How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology.” Toxicological Sciences 155 (2): 326–336. doi:10.1093/toxsci/kfw207.
  • Wu, H. C., X. Chang, L. Liu, F. Zhao, and Y. Zhao. 2010. “Chemistry of Carbon Nanotubes in Biomedical Applications.” Journal of Materials Chemistry 20 (6): 1036–1052.
  • Yan, H., Z. Xue, J. Xie, Y. Dong, Z. Ma, X. Sun, D. K. Borga, Z. Liu, and J. Li. 2019. “Toxicity of Carbon Nanotubes as anti-Tumor Drug Carriers.” International Journal of Nanomedicine 14: 10179–10194. doi:10.2147/IJN.S220087.
  • Yokel, R. A, and R. C. MacPhail. 2011. “Engineered Nanomaterials: Exposures, Hazards, and Risk Prevention.” Journal of Occupational Medicine and Toxicology 6 (1): 7–27. doi:10.1186/1745-6673-6-7.
  • Zhang, K, and R. J. Kaufman. 2008. “From Endoplasmic-Reticulum Stress to the Inflammatory Response.” Nature 454 (7203): 455–462. doi:10.1038/nature07203.
  • Zhang, T., M. Tang, L. Kong, H. Li, T. Zhang, S. Zhang, Y. Xue, and Y. Pu. 2012. “Comparison of Cytotoxic and Inflammatory Responses of Pristine and Functionalized Multi-Walled Carbon Nanotubes in RAW 264.7 Mouse Macrophages.” Journal of Hazardous Materials 219–220: 203–212. doi:10.1016/j.jhazmat.2012.03.079.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.